High Quality Aminoglycoside Antibiotics/Streptomycin Sulfate for Injection

• Customization: Available
• Application: Internal Medicine
• Usage Mode: Internal Use
• Model NO.: 1.0g, 5.0g
• Suitable for: Elderly, Children, Adult
• State: Solid
• Shape: Powder
• Type: Organic Chemicals
• Pharmaceutical Technology: Chemical Synthesis
• Transport Package: 10vials/Box; 50vials/Box
• Trademark: Reyoung
• Origin: China

Product Description

Functions and Indications
1. This product is mainly used in combination with other anti-tuberculosis drugs for newly treated cases of various tuberculosis caused by Mycobacterium tuberculosis, or other susceptible Mycobacterium infections. 2. This product can be used alone for the treatment of tularemia, or combined with other antibacterial drugs for the treatment of plague, inguinal granuloma, brucellosis, rat bite fever, etc. 3. It can also be used in combination with penicillin or ampicillin to treat endocarditis caused by Streptococcus viridans or Enterococcus.

ITEMS	SPECIFICATION	RESULT
Identification	Complies	Complies
Tests
Acidity or Alkalinity	5.5~7.5	6.85
Foreign matter	No detected	Not detected
Sub-visible particles	≥10um,≤6000Particles/Bottle	25.9Particles/Bottle
	≥25um,≤600Particles/Bottle	0.3Particles/Bottle
Pyrogen	Complies	Complies
Sterility	Complies	Complies
B Knanmycin B	Complies	Complies
Uniformity of weight	Complies	Complies
Assay	NLT 95.0% and NMT 115.0% of the labeled amount of kanamycin	100.00%

Reyoung Pharmaceutical Co., Ltd., established in 1966, is one of the leading manufacturer and distributor of pharmaceutical products in China. Reyoung Pharma is certificated by GMP, ISO9001, ISO14001, OHS18001. The trademark "REYOUNG" is famous trademark of China.

 As a professional pharmaceutical manufacturer, Reyoung Pharma is the first enterprise to manufacture powder for injection in Shandong province. The sales and marketing network for its products covers more than 70 countries all over the world.

Reyoung Pharma commenced international business and exported products in 1997. Reyoung Pharma, with an excellent sales & documentation team, owned over 20 years experience in the international transaction and registered products in different countries. Reyoung Pharma has passed the GMP inspection of Colombia, Peru, Congo, Ethiopia, Uganda, Nigeria, Ghana, Tanzania, Kenya, Cote d′Ivoire, Pakistan, Ukraine, Philippines, Cambodia, etc. Products have been exported to Asia, South America, Africa, CIS Countries, Middle East and Europe including Thailand, Philippines, Cambodia, Hong Kong, Vietnam, India, Pakistan, Colombia, Peru, Chile, Costa Rica, Venezuela, Congo, Ethiopia, Uganda, Nigeria, Tanzania, Kenya, Cameroon, Russia, Kazakhstan, Ukraine, Uzbekistan, Georgia, Yemen, Iraq, Germany, Denmark, and so on.

This product is used for treatment of moderate to severe infections caused by β-lactamase-producing bacteria that are resistant to cefoperazone monotherapy and sensitive to this product. When used for the treatment of mixed infections caused by cefoperazone single-drug-sensitive bacteria and cefoperazone single-drug-resistant β-lactamase-producing bacteria sensitive to this product, no additional antibiotics are required. Lower respiratory tract infection: susceptible to β-lactamase-producing Pseudomonas aeruginosa, Streptococcus pneumoniae and other Streptococcus, Klebsiella pneumoniae and other Klebsiella species, Haemophilus influenzae, Staphylococcus aureus, etc. bacterial pneumonia, acute exacerbations of chronic bronchitis, acute bronchitis, lung abscesses and other lung infections. Urogenital infection: acute pyelonephritis, acute pyelonephritis caused by sensitive bacteria such as β-lactamase-producing Escherichia coli, Proteus, Klebsiella, Pseudomonas aeruginosa, and Staphylococcus Exacerbations, complicated urinary tract infections, endometritis, gonorrhea, and other reproductive tract infections. Abdominal and pelvic infections.